|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1993-2-12
|
|
pubmed:abstractText |
There is no generally accepted treatment for human immunodeficiency virus (HIV)--associated idiopathic thrombocytopenic purpura (ITP). recombinant alpha interferon (rIFN) has been used in classic ITP with conflicting results. We have tested its activity in a group of intravenous drug users (IVDUs) with HIV-associated ITP, who also had a high prevalence of chronic liver disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
418-20
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1483592-Adult,
pubmed-meshheading:1483592-Drug Evaluation,
pubmed-meshheading:1483592-Female,
pubmed-meshheading:1483592-HIV Infections,
pubmed-meshheading:1483592-Humans,
pubmed-meshheading:1483592-Immunologic Factors,
pubmed-meshheading:1483592-Interferon-alpha,
pubmed-meshheading:1483592-Liver Diseases,
pubmed-meshheading:1483592-Male,
pubmed-meshheading:1483592-Platelet Count,
pubmed-meshheading:1483592-Purpura, Thrombocytopenic, Idiopathic,
pubmed-meshheading:1483592-Recombinant Proteins,
pubmed-meshheading:1483592-Substance Abuse, Intravenous,
pubmed-meshheading:1483592-Treatment Outcome
|
|
pubmed:articleTitle |
Interferon therapy in intravenous drug users with HIV-associated idiopathic thrombocytopenic purpura.
|
|
pubmed:affiliation |
I Divisione di Malattie Infettive, Spedali Civili di Brescia, Italy.
|
|
pubmed:publicationType |
Journal Article
|
